Moving screening and prevention care more upstream can help make an impact by getting patients diagnosed with cancer earlier, said Susan Sabo-Wagner, MSN, RN, OCN, executive director of clinical strategy for Oncology Consultants of Houston, Texas.
Screening and prevention of cancer needs to be a collaborative effort between oncology practices and primary care providers, explained Susan Sabo-Wagner, MSN, RN, OCN, executive director of clinical strategy for Oncology Consultants of Houston, Texas.
Transcript
Is there a way for oncology practices to partner with primary care providers to put more focus on screening and prevention?
This is a big initiative that we want to work with in our HOPE Initiative, eventually. We're starting right at the door when the patient is diagnosed, coming into our practice. We know that we can only make so much of an impact when a patient is diagnosed with cancer, right? However they come to us, if it's stage IV, if it's stage III, if it's stage I; however they come. We know, obviously, it would be much better if we can prevent it from being a stage IV, stage III, and that comes from screening and education and wellness and behavioral health.
One of the things that we believe is that if we can get our model upstream into primary care, the best way we can do that is if we can provide it in some kind of payer model so that people are actually incentivized to be able to do things like screening and prevention care and get out there and provide health literacy. Get out into the neighborhoods… we can see it on a map, who is not getting out there to get screened. So, if we can provide it in some kind of model where it is an entire package of primary care with specialty involved, and everybody is making their impact and being incentivized for it; while it sounds like a nice thing to do, making sure everybody's getting screened and getting their chronic illnesses and cancers caught early, it also will have to show some kind of [return on investment], and it has to be good for business and we believe that it can be. We believe that that's what is part of a really true value-based model.
If everyone got on board, we know there's research already out there, there's tons of research that shows the earlier that you intervene in a person's life, the better the outcomes are. As a cancer care center, we know that our specialty is an incredibly expensive specialty, but we didn't start it that way. We’re doing the best we can in terms of treating it and trying to keep costs down. But, we think that—not that someone else should do it and only them—we think that as a group from beginning to the end, we can all have an impact there.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen